← prelander teardowns

Side by side · CS-P1 top-5 ranking

Our page on the right, word for word. The kept page on the left, part by part, described in our words, with a link that opens their live page at those lines (their text and pictures are not copied here). The plan under each of their parts was written from the teardown, before our page: where our page went another way, the right column is what stands. Mark each part and leave a note. It saves as you go, and a mark on a part of ours shows on every comparison of that page.
Compare CS-P1 with
Theirs

Clarity MD · top-N ranking

The ingredient is sound; most bottles fail on dose, source or format, and a tester who tried the popular ones found a single product that passes all three at the lowest stated price.

1,819 words · brand named 14% down the page · 3 buttons, the first at 33% · house chief 6/10 · craft chief REVISE

Open their live page ↗ · the full teardown

Ours

The 5 Best Astaxanthin Supplements For Kidneys, Brain, Eyes & Joints

CS-P1 · 2,395 words · live since 2026-09-14, your Copy Studio rounds 1 and 2 applied; 11 proposed changes wait on your verdict

Open our live page ↗ · comment line by line in the Copy Studio

The order, at a glance

Each bar is one page from first word to last. Width is the share of the page's words. Click a block to jump to that part.

Theirs
astaxanthin named · 2%brand named · 11%first button · 0%
Ours
astaxanthin named · 3%brand named · 15%first button · 28%
OpeningHer storyWhat she triedThe turnThe cause and the reason whyProofThe productResultsDoubts and limitsThe askThe close

What we took from this page

  • Criteria before candidates: problem (entries 7-11), three named tests (12-15), one line of method (16), then the cards. The reader accepts the yardstick before learning who benefits from it.
  • Winner first, about a seventh of the way down (entry 17), not held back for a countdown; every later card is read against it.
  • The winner's first three pros mirror the three criteria in the same order (entry 18); trust points next, then guarantee, crowd and price last (entries 19-22).
  • Generous rival cards: each rival is granted what it truly passes and is marked down on price and terms (entry 34). Only the last rival fails a criterion outright (entries 52-54), which proves the yardstick bites.
  • Rival cards that send the reader back to rank one: the fallback line at the foot of the runner-up's card (entry 36) and the upward pointer at the foot of the value card (entry 42).
  • The link ladder: two soft links (entries 31, 63) and one hard link with the guarantee in its wording (entry 66); no link inside any rival card.
  • A re-crowning recap directly under the last rival (entries 56-60): heading, ticks in criteria order, the name last.
  • Proportion as argument: nine pros and two cons for the winner, three pros and seven cons for last place.
  • A three-beat second-person mirror of the failed purchase (entry 9), placed after the ingredient is cleared and before any blame is assigned.

What we left on it

  • The tester: a byline with no credential or trace (entry 4), a test with no data, dates or photographs (entry 16), a pool that grows from five to more than fifty (entry 56). Treat all three as invented.
  • Letter grades with no scoring sheet (entries 17, 32, 38), missing altogether on cards four and five (entries 44, 50).
  • Another publisher's small print under the rival cards (entries 37, 43 and 49) and a publication named only in the footer (entry 67).
  • Cosmetic and contradictory cons: plain packaging and no bonus ingredients (entry 40); the standard dose listed as a drawback (entry 46).
  • Their delivery criterion (entry 15): an oil-against-powder superiority claim is banned for us (b8).
  • Crowd and doctor claims with no source (entries 21, 26); our numbers wait for a measured panel (r17) and a named quote (r19).
  • Their ninety-day window and first-order discount wording: our offer is BRAND section 3 and the 30-Day Money-Back Guarantee.
  • Sold-out scarcity (entries 23, 36) unless a true stock statement exists.
  • A verdict with no point of view and praise that contradicts placement (entries 47, 48).
  • An unnamed felt result (entry 62): we name what the reader notices and in which weeks, from the gate.

Part by part · 15 paired · 25 theirs only · 4 ours only

I am
What the page admitstheirs at 0% of the wordstheirs only
Theirs, in our words
#1at 0%●●○○○cta · 2 words

A two-word link at the very top marks the page as advertiser-funded. The terms sit behind the click; nothing on the page itself says who pays or who owns the winner.

Why it works. Meet the disclosure duty in the spot readers skip, and borrow the look of an independent review site, where such a link is standard. candor

Why it sits here, and how it is written

It stands above the headline because that is where review publishers put theirs. A reader who meets it first files the page under comparison sites before any claim is made; placed after the pitch it would read as a confession.

Two words, no sentence. It works as costume more than as disclosure: the store that publishes the page also sells the product ranked first, and no line says so in plain words.

Planned for ours, before we wrote: store chrome. CS-P1 has no disclosure link at the top; its 'Advertorial' byline tag was removed on 2026-09-15 and the supplement disclaimer sits in the footer. Whether a top-of-page disclosure returns is David's call. If it does, it names CellScience in plain words.

Open on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The headlinetheirs at 0% of the words · ours at 0%
Theirs, in our words
#2at 1%●●●●●h1 · 10 words

A first-person tester says she tried five well-known astaxanthin products and will share which factors count. No brand is named and no health benefit is promised.

Why it works. Pick out the shopper who is already comparing bottles and promise a shortcut: the criteria, from someone who did the legwork. curiosity-gapearned-authorityspecificity

Why it sits here, and how it is written

The click comes from someone who believes in the ingredient and is stuck on which bottle. Opening on the test, not on a brand, lets the page pose as the answer to that search. The ranking only works once the reader has accepted a tester.

Ten words in two halves split by a colon: the deed, then the payoff. Five is small enough to believe. The second half is a stock review phrase any rival could run; the color sits in the first-person verb.

Planned for ours, before we wrote: kept the move. CS-P1's H1 is a third-person list title that names four organs; it has no tester and no promise of criteria. A headline built on the act of checking (every label read, on a stated date) is a hook to test against it, with the organs kept in the subhead. Claim only the checking we did.

See these lines on their page ↗
Ours, word for word
The 5 Best Astaxanthin Supplements For Kidneys, Brain, Eyes & Joints
The line under the headlinetheirs at 1% of the words · ours at 0%
Theirs, in our words
#3at 2%●●●○○p · 19 words

The deck widens the credential to study reading plus trying several brands, promises a short list of deciding factors, and brands the products that miss them as costly duds.

Why it works. Attach a money stake to choosing wrong and make the criteria feel owed. loss-aversionopen-loopcontrast

Why it sits here, and how it is written

Directly under the headline it turns curiosity into a stake before the byline can be questioned. The reader already suspects brands differ; the deck confirms it, so the criteria section below is awaited, not endured.

One sentence of nineteen words, front-loaded with two credentials. The closing two-word insult is the only vivid phrase on the first screen. The count of brands goes vague here where the headline was exact.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's subhead counts softgels, tests and one winner and names the organs: it states structure, not the cost of a wrong pick. The true version of their jab is ours to use: about 64% of unverified astaxanthin products fail potency testing (c1). CS-P1 holds that figure in the method box, not on the first screen. c1

See these lines on their page ↗
Ours, word for word

Five softgels, three tests, one winner for kidneys, brain, eyes and joints.

The picturetheirs at 2% of the words · ours at 1%in a different place on their page
Theirs, in our words
#6at 4%●●○○○img · 0 words

A wide, shallow hero picture spans the column. It has no alt text, so the rows cannot say what it shows.

Why it works. Break the text before the argument starts, as a news article would.

Why it sits here, and how it is written

It follows the byline and tabs and comes before the first subhead, the usual place for an article's lead picture. The opening argument therefore begins below the first screen.

It is the only picture in the extract. No product photograph in the five cards was large enough to be captured, if any exists. For a page that claims hands-on testing, no picture of a product in hand is the loudest gap.

Planned for ours, before we wrote: kept the move. CS-P1's hero is our own bag with a caption calling it the top pick, so our winner is revealed on the first screen; this page keeps its hero neutral and holds the winner back until the list. A neutral hero (the five rivals side by side) is a test worth boarding. CS-P1 already shows a branded still in every rival card.

Open on their page ↗
Ours, word for word
Picture caption: Our #1 pick: one 12 mg softgel a day, 30 to a bag, every batch third-party lab tested.
Who is speakingtheirs at 2% of the words · ours at 2%
Theirs, in our words
#4at 3%●●○○○2× p · 12 words

A bare byline with a woman's name, then an updated date in July 2026 and a four-minute reading time. No title, no credential, no publication beside the name.

Why it works. Give the first-person voice an owner and a recent date, and promise a short read. earned-authorityease

Why it sits here, and how it is written

It follows the deck because the 'I' of the headline needs a name before the argument starts. The date tells the shopper the ranking is current for the year in the page title.

Thin. A name with nothing behind it asks for trust in a stranger, and the reading time undersells a page of about 1,800 words. No bio, no link, no trace of her elsewhere: treat the tester as an invented persona.

Planned for ours, before we wrote: kept the move. CS-P1 already carries a heavier stamp: a named health editor with sixteen years on the beat, a headshot, a date, a nine-minute read and a press strip. Our editor is a generated persona as well (BRAND log 2026-09-14), so the same question of disclosure applies to us.

See these lines on their page ↗
Ours, word for word

By Ruth Calloway · Health Editor · 16 years covering supplements for readers over 50 Updated September 14, 2026 · 9 min read

As Featured In

  • Prevention
  • AARP
  • Reader's Digest
  • Men's Health
What she already triedtheirs at 2% of the words · ours at 3%
Theirs, in our words
#7at 6%●●●●○h3 · 8 words

The first subhead states that the majority of people who take the ingredient notice nothing, and implies the reason is coming.

Why it works. Name the disappointment the reader may already have and mark it as common. curiosity-gapconsensusidentification

Why it sits here, and how it is written

Before any science, the page tells the reader that a flat result is normal. It has to come ahead of the criteria, because the criteria are sold as the explanation for it.

Eight plain words, a question posed as a statement. It assumes the reader has bought the ingredient once already, which suits a comparison search and shuts out the newcomer.

Planned for ours, before we wrote: rewritten to our claims. Most of our market has never met astaxanthin (p7), so the failed bottle on our page is the multivitamin and the vitamin C that never reach the inside of the cell (p3, r3, r5). CS-P1's intro already opens there; it has no subhead that names the disappointment. Never the collagen-stalled story (p1, p2). p7p3r3r5

See these lines on their page ↗
Ours, word for word

If you are over 50, you have probably been told to take a multivitamin. Vitamin C. Vitamin E. Most of it never gets where it is needed. It moves through the bloodstream and leaves as waste, and the inside of the cell, where the damage happens, stays open. Astaxanthin is different. It is fat-soluble, so it settles into the cell membrane instead of passing through. That is why it has been studied for the kidneys, the eyes, the brain and the joints. It carries about 6,000 times the antioxidant power of vitamin C.

Proposed change 2 · Intro: her own cabinet waits on your verdict

The kept rankings open by replaying the reader's own mornings in short beats, before any science. Ours states it as a fact about the category.

If you are over 50, you have probably been told to take a multivitamin. Vitamin C. Vitamin E. You have taken them every morning for years. Most of it never gets where it is needed.

Proof: the researchtheirs at 3% of the wordstheirs only
Theirs, in our words
#8at 6%●●●○○p · 34 words

The writer grants what the reader has heard about the ingredient's strength, says the research supports it, gives a count of more than 70 studies and lists five areas of benefit.

Why it works. Protect the ingredient's reputation before blaming the products, so the reader's earlier purchase still looks like a sound idea. borrowed-authorityconsensusspecificity

Why it sits here, and how it is written

It comes ahead of the flat-result line so the failure cannot land on the ingredient. The reader has to go on believing in astaxanthin for a ranking of astaxanthin products to be worth reading.

Three sentences, the middle one five words long: a concession, a verdict, a number. No study, journal or link is named. The five benefit nouns in a row are the only benefit copy on the whole page.

Planned for ours, before we wrote: our proof in its place. CS-P1's intro already names the organs and the 6,000x figure (m3). Our study count is 60+ (r14) and the 'most powerful antioxidant in nature' line is cleared (r15). Where they leave the studies unnamed we can name trials: skin (b1), the screen-worker eye trial (b3), joints (b4). r14r15m3b1b3b4

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

“That is me”theirs at 5% of the wordstheirs only
Theirs, in our words
#9at 8%●●●●○p · 15 words

Three clipped second-person beats replay the reader's own purchase: the bottle, the months of taking it, the flat result.

Why it works. Win the first small yes: the reader recognises their own story. mirroringidentificationcommitment

Why it sits here, and how it is written

With the ingredient cleared, the page turns to the reader's experience, so the gap between a proven ingredient and a flat result becomes a puzzle. One line earlier it would have read as an attack on the ingredient.

The best-written line on the page. Fifteen words in three fragments with a trailing pause before the letdown. It sounds spoken. Nowhere else on the page is the reader the subject of the story.

Planned for ours, before we wrote: kept the move. CS-P1 has no second-person replay of a failed purchase; its intro speaks of what the reader was told to take. A three-beat mirror about the cabinet of vitamins fits our reader in their 60s and 70s (r3, r23). r3r23

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The causetheirs at 6% of the wordstheirs only
Theirs, in our words
#10at 8%●●●●○p · 23 words

The writer clears the ingredient a second time and moves the blame onto products that supply it in a form the body cannot take up.

Why it works. Name the villain: not the reader, not the ingredient, but the way most bottles are made. vindicationcommon-enemyreason-why

Why it sits here, and how it is written

It answers the puzzle the previous line opened. Criteria can only be introduced now, because a test needs a fault to look for. The blame falls on a whole category, so every rival below starts under suspicion.

A throat-clearing opener, then two short sentences in contrast. The quantity stays vague enough to be unfalsifiable. Plain words, nothing technical.

Planned for ours, before we wrote: rewritten to our claims. On our ranking page the honest villain is the unverified label: about 64% of unverified astaxanthin products fail potency testing (c1), and many brands sell 4 to 6 mg (b7). CS-P1 holds both points in its method box; its intro blames vitamins that pass through, not the category's bottles. c1b7

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 3 · Intro: the turn waits on your verdict

The kept pages turn from the cabinet to the reason in one step: the nutrient is sound, the bottle is the risk. That makes buying again reasonable. Our potency figure sits lower, in the method box.

Astaxanthin does reach the cell. But first the full dose has to be in the softgel. When outside labs test unverified astaxanthin products, about 64% fail on potency. So we bought the five products people over 50 actually buy and read every label.

The turntheirs at 7% of the wordstheirs only
Theirs, in our words
#11at 9%●●●●○p · 26 words

The writer says her own reading of the research surfaced three deciding factors, and pictures the alternative as a product that simply passes through the body.

Why it works. Hand over from problem to criteria, with the writer's homework as their source. earned-authorityopen-loopspecificity

Why it sits here, and how it is written

It is the hinge of the top third. The villain is named, so the reader now wants the test for it, and the count of three promises the test is short. It has to precede the list or the grades would have no yardstick.

One sentence of twenty-six words that ends on a bodily image, the strongest picture in the intro. A single reflexive pronoun does the work a credential would normally do.

Planned for ours, before we wrote: kept the move. CS-P1 has this hinge in the editorial plural: five products bought, every label read, three things ranked. Ours rests on reading each rival's own page on a stated date, which is true. One mismatch to fix: CS-P1's subhead says three tests and its method box lists five things; this page holds the count at three until the scoring line.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

How the list was rankedtheirs at 8% of the words · ours at 7%
Theirs, in our words
#12at 10%●●●●○h2 · 9 words

A section heading presents three factors as requirements for any product in the category.

Why it works. Turn the writer's view into a rule that the products below can pass or fail. specificityreason-why

Why it sits here, and how it is written

It sits between the problem and the list, so the yardstick is accepted before the reader knows who profits from it. A reader who agrees here has half agreed with the ranking.

Nine words with a number and a verb of obligation: the register of a buyer's guide.

Planned for ours, before we wrote: kept the move. CS-P1 has a method box headed as five deciding things. Keep it, but let the heading count match the three score bars on every card (the full 12 mg in one softgel, third-party lab tested, cost per day). b7c1

See these lines on their page ↗
#13at 11%●●●●○h3 · h4 · 7 words

Criterion one is dose, with 12 mg named as the amount clinical work uses. Only the title shows; the explanation is folded away.

Why it works. Set the number every product will be measured against, a number that happens to be printed on the seller's own label. anchoringborrowed-authorityspecificity

Why it sits here, and how it is written

Dose goes first because it is the easiest thing to check on a label and the one test the last-placed rival will fail. The first criterion frames how the other two are read.

Six words. The phrase borrows the authority of trials without citing one. With the body collapsed, the claim is asserted, not argued.

Planned for ours, before we wrote: kept the move. CS-P1 already leads its method box and its score bars with this: the full 12 mg in one softgel, the dose the human trials used (b7, b9). b7b9

See these lines on their page ↗
#14at 11%●●●○○h3 · cta · 6 words

Criterion two is origin: natural microalgae, tied in capital letters to how well the body can use the ingredient. The explanation is again folded away.

Why it works. Rule out synthetic product and link origin to absorption. reason-whycontrast

Why it sits here, and how it is written

After quantity comes quality: once 12 mg is accepted, the next doubt is whether all 12 mg are equal. Source precedes delivery because delivery only matters if the raw material is right.

The capitals shout where the first criterion spoke; the inconsistency looks like an unfinished template. The one technical word in the top third goes unexplained on the surface.

Planned for ours, before we wrote: kept the move. CS-P1's method box has this criterion and says openly that all five rivals pass it, so it did not decide the ranking: a candor move this page lacks. Rests on natural microalgae as the form the human studies used (c4), synthetic made from petrochemicals (r16), closed bioreactors (c5). c4r16c5

Open on their page ↗
#15at 12%●●●○○h3 · cta · 6 words

Criterion three is format, set up as a contest between oil-filled softgels and dry powder capsules.

Why it works. Add a format test that softgels pass and powder capsules fail. contrastreason-why

Why it sits here, and how it is written

Last of the three because it is the least intuitive: the reader needed dose and source first to care how the dose travels. It closes the loop the intro opened about a form the body can use.

Five words built on a versus. No product in the list is a dry powder, so this criterion eliminates nobody on the page: it explains the intro and sorts nothing.

Planned for ours, before we wrote: rewritten to our claims. A carrier-oil or oil-format superiority claim is banned for us (b8). What holds: astaxanthin is fat-soluble (r26) and is taken with a meal that has some fat (r31). CS-P1 does not use a delivery axis; its second bar is third-party lab tested (c1, c3), the test that does separate our product. r26r31c1c3

Open on their page ↗
#16at 13%●●●●○h2 · p · 27 words

The list's title repeats the page title with the year. One sentence of method follows: five popular products, scored on the three criteria plus a fourth, value, which was never introduced.

Why it works. Open the ranking and state the scoring basis in a breath, slipping in the yardstick that will do the real sorting. specificityearned-authority

Why it sits here, and how it is written

It stands at the threshold of the cards, where a method note is expected. The fourth criterion arrives here unargued because the three argued ones cannot rank products that all pass them.

Twenty-one words of method for the whole ranking: no protocol, no duration, no lab, no dates. A figure of speech does the work of evidence. The test is asserted and never shown; treat it as unverified.

Planned for ours, before we wrote: kept the move. CS-P1 states its method more fully (five points, each with its reason, including the 64% figure, c1) and shows scores per axis. Keep ours. Worth taking: one plain sentence of method directly above the first card. c1b7

See these lines on their page ↗
Ours, word for word

So we bought the five products people over 50 actually buy and read every label. We ranked them on three things that decide whether the bottle in your cabinet does anything. Is there a clinical dose of 12 mg from the studies in one softgel? Does it actually work? How much does it cost?

How we ranked them
The 5 things that decided this list
  • Is the full 12 mg in one softgel? — 12 mg a day is the dose the human trials used. One product on this list needs four softgels a day to get there.
  • Is it third-party lab tested? — About 64% of unverified astaxanthin products fail third-party potency tests. “Third-party tested” on a label is a claim. Verified lab results are proof.
  • Is it natural astaxanthin from microalgae? — The form the positive human studies used. All five pass, so it did not decide the ranking.
  • What does a day cost? — Worked out per day at the price on each brand’s own site, not per bottle.
  • Will you still be taking it on day 30? — One softgel with a meal is a routine that survives. Four a day, twice a day, is not.
Proposed change 4 · How we ranked them: the rule waits on your verdict

The strongest ranking you kept states its rule above the cards: qualify first, then rank. It lets a rival pass a test and still place lower, without the list contradicting itself.

One line under the five things: “To make this list, a product had to be natural astaxanthin from microalgae. All five are. The order comes from three scores: 12 mg in one softgel, third-party lab tested, and cost per day.”

A product cardtheirs at 11% of the words · ours at 15%
Theirs, in our words
#17at 14%●●●●●h2 · h3 · 2× p · 9 words

Card one names the seller's own 12 mg product as rank one, gives the maker line and stamps it with the top letter grade. This is the product reveal.

Why it works. Reveal the product as the winner of a test, not as the advertiser. anchoringearned-authority

Why it sits here, and how it is written

The winner comes first, about a seventh of the way down: a shopper who reads one card reads this one, and every later card is judged against it. The criteria just above make the grade feel derived.

Four rows, nine words. A letter grade is a shrewd unit: everyone has been graded at school, and a letter hides the absence of a scoring sheet. No sub-scores appear; the grade has no stated method.

Planned for ours, before we wrote: kept the move. CS-P1 already ranks our product first, with a ribbon and three numeric score bars. Ours is the stronger form because the axes are visible. Name it as CS-P1 does: CellScience Astaxanthin 12mg, The Cell Shield.

See these lines on their page ↗
#18at 17%●●●●●h2 · 3× p · 39 words

The first three plus points restate the three criteria in the same order (dose, source, delivery), each with a short reason after a colon.

Why it works. Show a clean sweep of the yardstick the reader accepted a minute ago. loop-closedreason-whyspecificity

Why it sits here, and how it is written

They lead the list while the criteria are still fresh; the matching order makes the grade look like arithmetic. Any other order would hide the fit.

Label, colon, reason: a mould a skimmer reads in two seconds a row. The first reason slips into the first person, which keeps the tester in the room. Row two holds the only named place of origin for an ingredient on the page.

Planned for ours, before we wrote: kept the move. CS-P1's winner pros open with dose and testing, matching its first two score bars (b7, b9; c1, c3); the third bar, cost per day, has no pro. Origin follows (c4, c5). Whether a cost-per-day pro returns to the card is David's call (price line removed 2026-09-15). No oil claim (b8). b7b9c1c3c4c5

See these lines on their page ↗
#19at 19%●●●○○3× p · 37 words

Three trust points follow: outside-lab checks of purity and strength, a free-from label, and domestic manufacture in a certified facility.

Why it works. Supply the quality signals a cautious buyer checks after the formula. borrowed-authorityobjection-preempt

Why it sits here, and how it is written

With the formula accepted, the next question is whether the label can be believed. These come before the money points so that price is read as a bonus on a sound product.

Same mould. No lab is named, no report linked, no batch number given: testing is claimed in a phrase. The free-from row is three hyphenated adjectives in a line.

Planned for ours, before we wrote: our proof in its place. Here our page is the stronger one: every batch third-party lab tested (c3, worded as 'lab tested' per the 2026-09-15 verdict) in a category where about 64% of unverified products fail (c1). Badges per r18: cGMP, Made in USA, gluten-free; vegan only if the shell is. CS-P1 has the testing line and no badge row in the card. c1c3r18

See these lines on their page ↗
Ours, word for word
#1 · our card

Editor's Choice

1 Best

Astaxanthin Softgels (resealable bag)

CellScience™ Astaxanthin 12mg — The Cell Shield

One softgel a day is the full 12 mg. Verified third-party lab results. Natural microalgae, grown in closed bioreactors. 30-day money-back, and you keep the bag.

Picture caption: One softgel with a meal: 12 mg of natural astaxanthin, 30 to a bag, every batch third-party lab tested.

12 mg in one softgel

10.0 / 10

Third-party lab tested

Cost per day

7.5 / 10

Why it took the top spot: It is the only product here that passes all three tests at once. The full 12 mg is in one softgel. Every batch is third-party lab tested, and the results are verified. And a month costs less than any rival except the two bargain bottles that ask you to take their word on the testing.

The astaxanthin is natural, from microalgae grown in closed bioreactors, so nothing from the outside world gets in. Because it is fat-soluble, it is absorbed with the fat in your meal instead of being flushed as kidney waste. That is why it is studied for the kidneys, the brain, the eyes and the joints. One softgel is less for your kidneys to handle than most multivitamins.

✓ Why readers are switching to this
  • The full 12 mg in one softgel — the dose the human trials used
  • Every batch third-party lab tested, results verified
  • Natural microalgae astaxanthin from closed bioreactors, no heavy metals
  • One softgel with a meal — the routine you keep
  • 30-day money-back guarantee, keep the bag; free shipping on every order
✗ Worth knowing
  • It is a daily supplement, not a treatment — keep your doctor and your labs
  • Sold only on the official site, never on Amazon or eBay
  • The 3-bag and 5-bag prices are launch pricing, and the bag says so
Proposed change 11 · Winner card: the picture waits on your verdict

The winner's picture is the product page's hero slide. It has six claims and a price banner set into the picture, so no copy gate reads them. One callout is the QR line you took out of this page on 2026-09-15, and the banner is a price line on a page where you removed the price paragraph. The two new story pages now show the plain pack for the same reason.

Replace the winner's picture with the plain pack (the bag on its cream ground, no words in the picture). The card's own text already carries the 12 mg, the lab testing and the guarantee. Alt text: “A bag of CellScience Astaxanthin 12 mg softgels”.

The guaranteetheirs at 16% of the wordstheirs only
Theirs, in our words
#20at 20%●●●●○p · 9 words

Plus point seven is the refund window: ninety days, with the promise put as a plain either-or.

Why it works. Remove the risk of being wrong a second time. risk-reversal

Why it sits here, and how it is written

It follows the trust points and precedes crowd and price: a reader burned by one flat bottle needs the exit before the numbers. Inside a pros list a guarantee reads as something the tester found, not a sales promise.

Nine words. The second half is a slogan with rhythm: two short clauses joined by a conjunction.

Planned for ours, before we wrote: our offer in its place. Ours is the 30-Day Money-Back Guarantee, keep the bag (BRAND section 3; the gate's 90-day wording in r22 is superseded by the lock of 2026-09-12). CS-P1's winner pros already end on it.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Proof: other peopletheirs at 17% of the wordstheirs only
Theirs, in our words
#21at 21%●●●○○p · 12 words

Plus point eight joins an unnamed medical endorsement to a customer count above 142,000 and a rating of 4.8 on a five-point scale.

Why it works. Show the crowd and an authority in a single row. social-proofborrowed-authorityspecificity

Why it sits here, and how it is written

Crowd proof lands after the guarantee and just before price: the reader has the facts and the exit and now learns they would not be alone. It is the only social proof until the verdict repeats it.

Label and reason do not match: the label promises doctors, the reason gives customers. No doctor is named and no review platform cited. Count and rating have no source; treat both as unverified.

Planned for ours, before we wrote: our proof in its place. CS-P1 shows a customer count and rating in its sidebar and a comment thread that is still placeholder text (a launch blocker). Our cleared routes are the consumer-panel block once it has run (r17) and the longevity-doctor quote (r19). No number before it is measured. r17r19

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The offertheirs at 17% of the wordstheirs only
Theirs, in our words
#22at 21%●●●●○p · 15 words

The last plus point is price: $29.99 for today, a first-order discount of up to 70 percent and free domestic shipping.

Why it works. Put the deal inside the review, so the reader reaches the link already knowing it. anchoringurgency

Why it sits here, and how it is written

Price closes the list: eight reasons first, the number last. Stated inside card one, it becomes the reference every rival price below is measured against.

Three offers in fifteen words. Two time words hint at a deadline without stating one. The discount ceiling and the single price do not add up on their face, and no reason for the discount is given.

Planned for ours, before we wrote: our offer in its place. Ours: one bag $29.99, three bags $59.97, five bags $89.95, free shipping on every tier (BRAND section 3; the five-bag tier carries x4). CS-P1 took the price line out of the winner card on 2026-09-15 and states price in the CTA block. This page shows what an in-card price does to the rival cards below; David's call. x4

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

A product cardtheirs at 18% of the wordstheirs only
Theirs, in our words
#23at 22%●●●○○h2 · 2× p · 20 words

The winner's two minus points: it is sold only through the maker's own site, and multi-packs run out during sales.

Why it works. Look balanced while adding exclusivity and scarcity. candorexclusivityscarcity

Why it sits here, and how it is written

A pros list with no cons would break the review format. They follow the price, so the first thing the reader does with the price is worry about availability.

Two rows against nine. Neither is a fault in the product; both are reasons to act now. It is the oldest device in the format and a careful reader will see through it.

Planned for ours, before we wrote: kept the move. CS-P1's 'worth knowing' block has the same two (official site only, r29; launch pricing on the multi-bag tiers) and adds a real limit: it is a daily supplement, not a treatment. Keep the real limit first; it is what makes the block believable. r29

See these lines on their page ↗
#24at 23%●●●○○h3 · p · 23 words

Under a verdict label the tester says this was the only product that asked for no trade-off and that it has everything on her list.

Why it works. Turn the list of points into a personal judgement. earned-authoritycontrast

Why it sits here, and how it is written

Lists persuade skimmers; a judgement in a voice persuades readers. It follows the cons so the last word on the product is the tester's and not the drawbacks'.

Two sentences, twenty-one words. The first carries a real idea (no trade-off). The second is filler that could sit on any product page.

Planned for ours, before we wrote: kept the move. CS-P1 has this as a boxed paragraph explaining the top spot: the only product that passes all three tests at once. Same move, more specific. Keep ours. b7c1c3

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Why this onetheirs at 20% of the wordstheirs only
Theirs, in our words
#25at 25%●●○○○2× p · 62 words

Two paragraphs replay the formula and the trust points as prose: dose, softgel and algae origin set against cheaper synthetic product, then testing, facility and label named as what settled it.

Why it works. Give the reader who skipped the list the same case in sentences, with a swipe at unnamed cheap brands. contrastcommon-enemyreason-why

Why it sits here, and how it is written

The repetition is deliberate: the page is built so that a reader entering at any point meets the three criteria. The swipe at synthetics is safe here because none of the four rivals below is synthetic.

It sags. Both paragraphs are lists in sentence clothing, thirty-one words each. The one lively phrase is the jab about petrochemicals; a short idiom of decision keeps the voice alive.

Planned for ours, before we wrote: our proof in its place. CS-P1's winner body does this in two paragraphs with our facts: natural microalgae (c4), closed bioreactors (c5), fat-soluble so less for the kidneys to handle (r26), and the organs named. The contrast with synthetic product is cleared (r16). c4c5r16r26

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Proof: other peopletheirs at 24% of the wordstheirs only
Theirs, in our words
#26at 27%●●●○○p · 43 words

The verdict ends on numbers: the customer count, the rating and the doctors again, then the routine (one softgel daily, thirty in a pouch) and the ninety-day window.

Why it works. Close the verdict on crowd, ease and safety in one paragraph. social-proofeaserisk-reversal

Why it sits here, and how it is written

The crowd comes last in the verdict, so the personal judgement is backed by numbers just before the bottom line restates the deal.

Forty-three words, the longest paragraph in the card, and it changes subject twice. Its opening clause admits the numbers are there as backup, which is honest about their job.

Planned for ours, before we wrote: our proof in its place. Ours: one softgel a day with a meal (b9, r31), thirty to a bag, the 30-Day Money-Back Guarantee. Crowd numbers only once measured (r17). CS-P1 has the routine and the guarantee in the winner pros and no crowd line in the card. b9r31r17

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Why this onetheirs at 26% of the wordstheirs only
Theirs, in our words
#27at 28%●●○○○h3 · p · 25 words

A bottom-line label, then a contrast: many brands cut corners on each of the three criteria, and this one is pitched at buyers who refuse the shortcut.

Why it works. Recast the three criteria as three ways rivals cheat, and flatter the buyer. common-enemycontrastidentification

Why it sits here, and how it is written

A second summary label inside one card gives the scanner another entry point. It turns the criteria from tests into accusations just before the price is repeated.

Two sentences. The first is a tidy three-part list that maps one to one onto the criteria. The second ends on a cliché.

Planned for ours, before we wrote: rewritten to our claims. We may say brands underdose at 4 to 6 mg (b7), that synthetic astaxanthin is made from petrochemicals (r16) and that most unverified products fail potency tests (c1). We may not make the capsule-against-oil point (b8). CS-P1 has no second summary inside the winner card. b7r16c1

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The offertheirs at 28% of the wordstheirs only
Theirs, in our words
#28at 29%●●●○○p · 34 words

One sentence stacks the three criteria and then the deal: today's price, the first-order discount and free shipping.

Why it works. Tie the price to the three reasons, so the number reads as low for what it buys. anchoringreason-why

Why it sits here, and how it is written

Second statement of the price, now in a sentence that leads with value. It sits three rows above the link, so the deal is the freshest thing in mind at the click.

Thirty-four words in a single sentence that reads like a list with commas. A two-word pivot marks where it turns from product to price.

Planned for ours, before we wrote: our offer in its place. CS-P1 keeps price out of the winner card (David's edit of 2026-09-15) and puts the per-bag price of the five-bag tier in the CTA block under it. Same slot, one step lower on the page. x4

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The guaranteetheirs at 29% of the wordstheirs only
Theirs, in our words
#29at 30%●●●●○p · 40 words

The card's last paragraph notes the absence of fillers, restates the ninety-day refund and argues that the window is long enough for a fair trial.

Why it works. End the card on safety, and give the length of the window a reason. risk-reversalreason-whyobjection-preempt

Why it sits here, and how it is written

The guarantee is the last argument before the link because the doubt left, after one flat bottle, is whether this one will differ. Giving the ninety days a purpose answers how long until the reader will know.

Three sentences. The filler point is a stray that belongs with the label claims. The final sentence gives the guarantee a job, which most guarantee copy forgets.

Planned for ours, before we wrote: our offer in its place. 30-Day Money-Back Guarantee, keep the bag. Our window is shorter, so its reason is what shows inside thirty days: steadier energy in weeks one to two (r7), eye strain relief in 14 to 28 days (b6). CS-P1 says this in its FAQ and timeline, not in the winner card. r7b6

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What the page admitstheirs at 32% of the wordstheirs only
Theirs, in our words
#30at 32%●○○○○fine · 25 words

Small print under the winner's card says outcomes reflect individual users and are not typical, and refers the reader to the product's own site.

Why it works. Legal cover for the claims in the card.

Why it sits here, and how it is written

It sits between the last argument and the link in the smallest type on the page: present for a regulator, invisible to a reader moving toward the click.

Boilerplate of twenty-five words. It speaks of users' experiences although the card quotes no user.

Planned for ours, before we wrote: store chrome. CS-P1 carries the supplement disclaimer once, in the footer. No per-card small print is needed.

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 9 · Every card: where the facts came from waits on your verdict

The kept pages print the basis of each card in small type under it. Ours has the dates in the builder's notes and not on the page. A dated source is true, it is fair to the rival, and it protects the page with ad reviewers.

Small print under each rival card: “Label, serving and price read on the brand's own product page, September 14, 2026.” Under our card: “Label, serving and price read on the CellScience product page, September 28, 2026.” Both dates are fixed text. The date on our card is the day the page is rebuilt.

The buttontheirs at 33% of the words · ours at 28%
Theirs, in our words
#31at 33%●●●●○p · 5 words

The first link out: a low-pressure invitation to read more about the winner, with an arrow. It asks for a look, not a purchase.

Why it works. Offer the smallest next step to the reader who is already persuaded. commitmentease

Why it sits here, and how it is written

It stands at the end of card one, a third of the way down: the first point at which the whole case (criteria, grade, price, guarantee) has been made once. Any earlier and the review pose would break.

Five words and a plain verb. Keeping the word for buying out of the link keeps the page in character as a review.

Planned for ours, before we wrote: kept the move. CS-P1 already places its primary CTA block directly after the winner card, with a harder button that carries the guarantee. A softer text link in the same slot is a test, not a gap.

See these lines on their page ↗
Ours, word for word
Try The Cell Shield With A 30-Day Money-Back Guarantee

From $17.99 a bag on the 5-bag supply · free shipping · 30-day money-back guarantee

Try The Cell Shield Risk-Free 30-day money-back guarantee
🔒 Secure checkout · One-time purchase, no subscription · Free US shipping
A product cardtheirs at 33% of the words · ours at 30%
Theirs, in our words
#32at 34%●●●○○2× h2 · 2× p · 9 words

Card two names Rovina's 12 mg product at rank two with the next grade down, a single step below the top.

Why it works. Set up a close runner-up so the ranking looks like a contest. contrastcandor

Why it sits here, and how it is written

It follows the winner's link: the reader who did not click now sees that the reviewer can praise a competitor. A near-equal second place is what makes first place believable.

The same four-row header as card one, so the eye compares like with like. The gap is one grade step.

Planned for ours, before we wrote: kept the move. CS-P1 also has Rovina at rank two, marked down on its dose axis: four softgels a day to reach 12 mg, read on its own page on 2026-09-14. The two pages disagree on facts (this one says the count per bottle is not listed; we found sixty to a bag). Use only what we read ourselves.

See these lines on their page ↗
#33at 36%●●●○○h2 · 5× p · 32 words

Five plus points credit the rival with the full dose, algae origin, a coconut-oil base, a ninety-day refund and independent checks: it passes every criterion.

Why it works. Concede the formula to the rival in full. candorconsensus

Why it sits here, and how it is written

Praise comes first: a rival that passes all three criteria proves the criteria were not rigged for one brand. It has to precede the cons so the markdown reads as fair.

Shorter rows than the winner's, five to seven words each, and nine rows shrink to five. The brevity is itself a ranking signal.

Planned for ours, before we wrote: kept the move. CS-P1's rival cards each carry three pros, every one read from the rival's own page. Same move; ours is sourced.

See these lines on their page ↗
#34at 38%●●●●○h2 · 4× p · 27 words

Four minus points, none about the formula: a price near $39.99, best pricing tied to auto-ship, softgel count not shown, and online-only sales.

Why it works. Mark the rival down on money and buying terms. anchoringloss-aversioncontrast

Why it sits here, and how it is written

The rival's price appears only after the winner's $29.99 has been stated twice, so ten dollars more needs no comment. Commercial cons keep the markdown defensible.

The mould again, six words a row. The online-only point is the same fact the winner's own cons carried as exclusivity: the page faults a rival for what it treats as a virtue in itself.

Planned for ours, before we wrote: kept the move. CS-P1 marks Rovina down on routine (four softgels a day), supply (fifteen days to a bag) and test results available only on request, with price shown as a tier symbol. Ours is stronger because each con is a label fact. Do not borrow theirs.

See these lines on their page ↗
#35at 40%●●●○○h3 · 2× p · 104 words

The verdict praises the rival's fundamentals, places it just behind the winner on price and sales model, flags the missing softgel count and credits its refund window.

Why it works. Explain the one-step gap in the tester's voice and show fairness. candorreason-whycontrast

Why it sits here, and how it is written

The reader has seen equal formulas and needs a reason for unequal grades. The prose supplies it and names the winner again inside the rival's card.

A paragraph of sixty-six words, then one of thirty-six. Conversational and exact on price. It repeats the cons nearly item for item.

Planned for ours, before we wrote: kept the move. CS-P1's rival bodies have the same shape: two paragraphs, praise first, then label facts. Already there.

See these lines on their page ↗
#36at 44%●●●●○h3 · p · 42 words

The rival's bottom line recommends it only as the fallback should the winner be out of stock, then repeats that it costs more but is an honest formula with a long refund window.

Why it works. Turn the runner-up into a reminder that the winner may run out. scarcitycandoranchoring

Why it sits here, and how it is written

It closes the strongest rival's card, the point where a reader might defect. The fallback framing sends them back up the page, and no link to the rival is offered.

The opening conditional is the cleverest sentence in the rival cards: a recommendation that sells the other product.

Planned for ours, before we wrote: rewritten to our claims. CS-P1's rival cards end on a price tier and a short verdict tag, not on a fallback line. The device transfers only with a true stock statement; we have launch pricing on the multi-bag tiers, not a stock limit. Without one, the pointer back to rank one is the part to keep.

See these lines on their page ↗
Ours, word for word
#2 · rival card

2 Rank

Astaxanthin Softgels (bag)

Rovina Astaxanthin 12mg

The one you have seen in ads. Natural astaxanthin in coconut oil, with a catch on the label: four softgels a day to reach 12 mg.

12 mg in one softgel

5.0 / 10

Third-party lab tested

6.0 / 10

Cost per day

4.0 / 10

Rovina gets the source right. Its astaxanthin comes from the same microalgae ours does, and it sits in organic coconut oil. The bag is resealable and the guarantee is a generous 90 days.

Then read the directions. Two softgels in the morning and two in the evening. That is four a day to reach the 12 mg serving, and a bag of 60 lasts 15 days. The brand says every batch is third-party tested; the results are available on request rather than posted. At the price we saw, a month is two bags.

✓ Pros
  • Natural astaxanthin from microalgae, in organic coconut oil
  • 90-day money-back guarantee
  • Made in a GMP-certified, FDA-registered facility
✗ Cons
  • Four softgels a day, morning and evening, to reach 12 mg
  • A 60-softgel bag is a 15-day supply
  • Batch test results on request, not posted

$$$$ · four softgels a day The right source, the wrong routine

Proposed change 1 · Rival cards: the order waits on your verdict

On the rankings you kept, a rival's place matches its scores. Ours puts the lowest-scoring product second, and BioAstin's text says it earns the second spot while it sits third. A reader who checks the bars sees the list disagree with itself.

Order the four rivals by our own three scores: #2 Sports Research · #3 BioAstin · #4 Dr. Mercola · #5 Rovina. BioAstin's sentence becomes two: “BioAstin has been on shelves longer than anyone here. It earns third place on the label alone.”

Proposed change 8 · Rovina card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who wants the 90-day guarantee, and does not mind four softgels a day.”

What the page admitstheirs at 45% of the wordstheirs only
Theirs, in our words
#37at 45%●○○○○fine · 22 words

Small print under the rival's card credits the results to a named ranking system that belongs to another review publisher: a leftover from the template this page was cloned from.

Why it works. Legal cover, left unedited.

Why it sits here, and how it is written

It sits at the foot of each rival card by template habit. Its content gives away the page's origin: the chassis of a third-party review site, reused by a seller.

A tell. The system it names appears nowhere else on the page, and the footer claims a different publisher. Treat the ranking system as nonexistent here.

Planned for ours, before we wrote: left out. Nothing to take. CS-P1's builder asserts that no donor string survives the purge; keep that assertion.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

A product cardtheirs at 46% of the words · ours at 39%
Theirs, in our words
#38at 47%●●○○○2× h2 · h3 · p · 11 words

Card three names Double Wood's product at rank three, with a grade in the B band, one step below the runner-up.

Why it works. Open the value tier of the ranking. contrast

Why it sits here, and how it is written

By the third card the reader expects a drop. The step from the A band to the B band marks where nearly-as-good ends and good-for-the-money begins.

The same header mould. The grade ladder so far is evenly spaced, which makes it look computed.

Planned for ours, before we wrote: kept the move. CS-P1's rank three is BioAstin; Double Wood is not in our list. Keep our own four rivals, each verified on its own page and each the same species of product (CL-13).

See these lines on their page ↗
#39at 49%●●●○○h2 · 4× p · 29 words

Four plus points: a full 12 mg of a branded extract, outside testing in a certified US facility, about $25.95 for sixty softgels, and a free-from formula.

Why it works. Concede that a cheaper product passes the criteria. candorspecificity

Why it sits here, and how it is written

The lower price is admitted openly, two cards after the winner's price was set. The page has to deal with the bargain somewhere and does it mid-page, where fewer readers are.

The branded extract name appears unexplained; a stranger would not know it is an ingredient supplier. The price row is the most exact on the page: dollars, cents and count.

Planned for ours, before we wrote: kept the move. CS-P1 concedes value openly in its Sports Research card (lowest cost per day on the list). Already there.

See these lines on their page ↗
#40at 51%●●○○○h2 · 5× p · 38 words

Five minus points, all cosmetic or circular: a plain bottle, no added vitamins, olive oil as the carrier, mostly direct sales, and no bonus ingredients. The second and fifth are one point stated twice.

Why it works. Mark down a product that beats the winner on price per softgel, without touching its formula. contrastanchoring

Why it sits here, and how it is written

The rival passed all three criteria and costs less for twice the count, so the markdown has to come from outside the criteria. The cons follow the price row at once, to blunt it.

The weakest list on the page. Packaging is not a criterion, and a single-ingredient formula is what the winner is too. A reader doing the arithmetic will see the winner costs more per softgel.

Planned for ours, before we wrote: left out. We do not invent cosmetic faults: CS-P1's rule is rival copy that is accurate and fair, every line read on the rival's page. Where a rival is cheaper, CS-P1 says so and wins on the lab-testing bar (c1, c3). c1c3

See these lines on their page ↗
#41at 54%●●●○○h3 · 2× p · 87 words

The verdict admits surprise, credits the full dose at about $26 in an olive-oil base and the testing, and concedes only a plain bottle and no extra antioxidants.

Why it works. Earn credibility by praising a bargain. candorspecificity

Why it sits here, and how it is written

Mid-page, with the winner's case already made, generous praise costs little and buys trust for the final recommendation.

It opens on a three-word sentence with real voice, and the quip about looks is the only joke on the page. Thirty-two and fifty-three words: the praise outruns the criticism.

Planned for ours, before we wrote: kept the move. CS-P1 does this in its value-pick card, which opens by granting that the rival would win on price alone. Already there.

See these lines on their page ↗
#42at 57%●●●○○h3 · p · 52 words

The bottom line calls the rival one of the best values listed and sends readers who care about extras or presentation back up the ranking.

Why it works. Send the quality-minded reader upward and let the price-minded one leave content. candorcontrast

Why it sits here, and how it is written

At the foot of the value card the page sorts readers by motive. The upward pointer is the only navigation cue inside the rival cards.

Four sentences, forty-nine words. The pointer is a quiet call to action with no link attached.

Planned for ours, before we wrote: kept the move. CS-P1's cards end on a verdict tag with no pointer back to rank one. A one-line pointer at the foot of our value-pick card is worth adding.

See these lines on their page ↗
Ours, word for word
#3 · rival card

3 Rank

Astaxanthin Gelcaps (bottle)

BioAstin Hawaiian Astaxanthin 12 mg

The old name in the category, grown in Hawaii. The full 12 mg in one gelcap, and no batch results anywhere on the page.

12 mg in one softgel

9.5 / 10

Third-party lab tested

3.0 / 10

Cost per day

8.5 / 10

BioAstin has been on shelves longer than anyone here, and it earns the second spot on the label alone. One gelcap is the full 12 mg, taken with food, from microalgae grown on the Kona coast. Bought by the 120, it is one of the cheapest days on this list.

What it does not give you is proof. We could not find a third-party test or a batch report on the product page. The gelcap is bovine gelatin in safflower oil. The guarantee is 45 days, and the company may ask for the unused portion back. When we checked, both bottle sizes were out of stock on its own site until October.

✓ Pros
  • One gelcap a day is the full 12 mg
  • Grown in Hawaii from microalgae; sold almost everywhere
  • One of the lowest costs per day when you buy the 120-count
✗ Cons
  • No third-party test or batch report on the product page
  • Bovine gelatin gelcap; the 45-day guarantee may ask for the product back
  • Out of stock on its own site until October when we checked

$ · one gelcap a day The name you know, without the paperwork

Proposed change 6 · BioAstin card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who trusts the oldest name on this list, and buys the 120-count.”

What the page admitstheirs at 58% of the wordstheirs only
Theirs, in our words
#43at 59%●○○○○fine · 22 words

The same leftover small print as under card two, crediting another publisher's ranking system.

Why it works. Legal cover, left unedited.

Why it sits here, and how it is written

Template position, the foot of every rival card. Repeated word for word, it becomes easier to notice with each card.

Identical to the line under card two. Repetition makes the borrowed chassis easier to spot.

Planned for ours, before we wrote: left out. Nothing to take; CS-P1 has no per-card small print.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

A product cardtheirs at 60% of the words · ours at 49%
Theirs, in our words
#44at 60%●●○○○h2 · h3 · p · 9 words

Card four names Sports Research's product at rank four. The grade label prints, but no letter reaches the text rows: the grade is an image or missing.

Why it works. Continue the descent. contrast

Why it sits here, and how it is written

Fourth place is where attention is thinnest. The card is there to make five, and to hold a well-known retail brand below the winner.

From here the template frays: a label for the grade with nothing readable beside it.

Planned for ours, before we wrote: kept the move. CS-P1 has Sports Research at rank four too, with three score bars in live text. Keep ours.

See these lines on their page ↗
#45at 62%●●○○○h2 · 3× p · 20 words

Three plus points, each a pair of claims: full dose in a triple-strength softgel, a vegan shell with coconut oil, and non-GMO verification with outside testing.

Why it works. Concede the criteria a third time. candor

Why it sits here, and how it is written

Praise opens the card as in the two before it; by now the reader takes the pattern for fairness.

The separator changes from a colon to a middle dot, and each row packs two claims with no reason given. A different hand, or a different source, filled in this card.

Planned for ours, before we wrote: kept the move. CS-P1's card for this rival has three pros read from its own page. Already there.

See these lines on their page ↗
#46at 64%●●○○○h2 · 5× p · 55 words

Five minus points: an unbranded algae extract, a daily cost above that of bulk tubs, a dose called more than occasional users need, storage that varies because many retailers carry it, and no lower-strength option.

Why it works. Find reasons to rank a product that passes every criterion fourth. contrastreason-why

Why it sits here, and how it is written

With formula, price and testing conceded, only traceability and retail handling are left to fault. They appear in the fourth card, where scrutiny is lowest.

Two of the five contradict the page's own first criterion: the dose the page calls the standard is here a drawback. It is the clearest sign that the rival cards were filled in without reading the top of the page.

Planned for ours, before we wrote: left out. Nothing here transfers. CS-P1 marks this rival down on one thing: a tested badge with no batch report to open, against our third-party lab testing (c1, c3). c1c3

See these lines on their page ↗
#47at 67%●○○○○h3 · p · 39 words

A one-paragraph verdict describes the product neutrally: full dose from algae in coconut oil, a plant-based shell that is rare among the five, sixty softgels for two months.

Why it works. Describe without judging. candor

Why it sits here, and how it is written

The verdict slot has to be filled for the card to match the others; nothing here moves the reader.

It reads like a product listing. The first person vanishes for thirty-seven words.

Planned for ours, before we wrote: kept the move. CS-P1's body for this rival has a point of view in both paragraphs (the value, then the missing report). Keep ours.

See these lines on their page ↗
#48at 69%●●○○○h3 · p · 72 words

The bottom line calls the product easy to trust, repeats its strengths, reduces the complaints to two minor ones and ends by recommending it to the majority of buyers.

Why it works. Keep the reviewer's fairness intact. candor

Why it sits here, and how it is written

It closes a card that had little to say against the product. Its praise is affordable this low on the page, where few undecided readers remain.

Sixty-nine words, the longest paragraph among the rival cards, and it undercuts the rank: a product judged sound for nearly everyone sits fourth with no grade. Praise and position do not match.

Planned for ours, before we wrote: left out. A rank has to follow from the scores. CS-P1's three bars make each position checkable; do not take praise that contradicts placement.

See these lines on their page ↗
Ours, word for word
#4 · rival card

4 Rank

Astaxanthin Veggie Softgels (bottle)

Sports Research Astaxanthin 12mg

The best value here: 12 mg in one veggie softgel at the lowest price per day. It shows a tested badge, and no batch report.

12 mg in one softgel

9.5 / 10

Third-party lab tested

5.0 / 10

Cost per day

If price decided this list, Sports Research would win it. Sixty veggie softgels for under thirty dollars, each one the full 12 mg from Icelandic microalgae in organic coconut oil. Made in a cGMP facility in the United States. Two months for the price of one of some rivals.

Then look for the test. The page shows a “Third Party Tested” badge, and that is where it stops. There is no batch report to open and no lot number to check it against. The guarantee badge says “satisfaction” and does not say how long. For a supplement you will take for years, we wanted the paper.

✓ Pros
  • 12 mg in one veggie softgel, with organic coconut oil
  • The lowest cost per day on this list
  • Made in cGMP facilities in the United States
✗ Cons
  • A “tested” badge with no batch report you can open
  • The guarantee does not state a term on the product page
  • A bottle, so the softgels see light every time you open it

$ · one softgel a day The value pick, on trust

Proposed change 5 · Sports Research card: who it suits waits on your verdict

On the kept pages each rival card ends on who should still buy it. It reads as fair, and it lets the reader place herself.

Last line of the card: “Who it suits: the buyer who wants the lowest cost per day, and will take the testing on trust.”

A product cardtheirs at 72% of the words · ours at 59%
Theirs, in our words
#50at 73%●●○○○h2 · h3 · p · 9 words

Card five names Life Extension's product in last place. Again the grade label prints with no letter in the text rows.

Why it works. Introduce the one product that will fail a criterion. contrast

Why it sits here, and how it is written

Last place is kept for the best-known catalogue brand: the biggest name falls furthest, which flatters the unknown winner.

The same frayed header as card four.

Planned for ours, before we wrote: kept the move. CS-P1's rank five is Dr. Mercola, marked down on cost per day and on no test report on its page. Life Extension is not in our list.

See these lines on their page ↗
#51at 75%●●○○○h2 · 3× p · 42 words

Three plus points: an established name with quality control, phospholipids added to aid absorption, and a low price of about $12 a month.

Why it works. Grant the rival its reputation and its price before the dose is attacked. candoranchoring

Why it sits here, and how it is written

The low price is conceded first so that the cons can undo it. The reader has to hold the $12 figure in mind for the dose arithmetic that follows to bite.

The third row mixes a price with a remark about broad marketing, two unrelated points in sixteen words.

Planned for ours, before we wrote: kept the move. CS-P1 grants each rival its real strengths before the facts that mark it down. Already there.

See these lines on their page ↗
#52at 77%●●●●○h2 · 7× p · 116 words

Seven minus points, the page's longest list: 4 mg a softgel against the 12 mg standard, a triple daily count to match it, a proprietary blend, a small bottle, a marine source, and a cost that climbs at full dose.

Why it works. Show one product failing the criteria outright, so the criteria are seen to bite. contrastreason-whyspecificityloss-aversion

Why it sits here, and how it is written

The only outright failure is kept for last place. It is the payoff of criterion one: a familiar, cheap brand fails on dose, which proves the yardstick was worth learning.

The first two rows and the sixth are strong and arithmetical. Then the list pads: the rows on bottle size and softgel type are filler, and the last repeats a phrase from the pros. Seven rows against the winner's two is proportion used as argument.

Planned for ours, before we wrote: rewritten to our claims. The contrast is cleared for us: 12 mg clinical strength against brands that sell 4 to 6 mg (b7). CS-P1's list has no underdosed rival, since all five are 12 mg products (CL-13), and its dose bar separates on softgels per day. An underdosed fifth card needs a same-species rival whose label we read ourselves. b7

See these lines on their page ↗
#53at 82%●●●●○h3 · p · 78 words

The verdict trusts the brand and likes its absorption aid, then turns on the label number: 4 mg equals one third of the research dose, so it takes three softgels daily to equal one from the top picks.

Why it works. Make the dose failure feel like arithmetic, not opinion. reason-whyspecificitycandor

Why it sits here, and how it is written

The list stated the fault; the prose proves it with division. It comes at the bottom of the ranking so that the last thing learned from the rivals is that dose decides.

Seventy-six words, the longest and best-reasoned paragraph on the page. It closes on a three-part sentence that pays two compliments before naming the fault.

Planned for ours, before we wrote: kept the move. CS-P1 does the same arithmetic in its Rovina card (four softgels a day, a bag lasts fifteen days), from that rival's own directions. Already there. b7

See these lines on their page ↗
#54at 85%●●●●○h3 · p · 55 words

The bottom line says the product does no harm, repeats that 4 mg is an underdose, and argues that the low-priced bottle stops being a bargain once enough softgels are taken to reach 12 mg.

Why it works. Flip the rival's price advantage into a cost. anchoringreason-whyloss-aversion

Why it sits here, and how it is written

It is the last rival sentence before the winner returns. Ending the ranking on the idea that cheap is not cheap shields the winner's price from the cheaper bottles in the list.

Fifty-two words. The closing clause points away to an unnamed elsewhere instead of naming the winner, which keeps the reviewer's tone.

Planned for ours, before we wrote: kept the move. CS-P1 scores cost per day on every card, so the per-day arithmetic is already a bar, not a remark. Keep ours.

See these lines on their page ↗
Ours, word for word
#5 · rival card

5 Rank

Astaxanthin Capsules (bottle)

Dr. Mercola Organic Astaxanthin 12 mg

A doctor’s catalogue brand with an organic claim on the label. The full 12 mg in one capsule, at a price that adds up over a year.

12 mg in one softgel

9.5 / 10

Third-party lab tested

3.0 / 10

Cost per day

6.0 / 10

Mercola ticks the first box cleanly: one capsule with a meal is the full 12 mg, and the label says organic. If you already order from the catalogue, it is an easy add.

The price is the story. Thirty capsules cost more than a month of any other product here except Rovina, and the 90-count does not close the gap by much. We found no third-party test or batch report on the product page, and no guarantee term stated beside the product.

✓ Pros
  • One capsule a day is the full 12 mg
  • An organic astaxanthin claim on the label
  • Easy to add to an existing catalogue order
✗ Cons
  • Among the highest costs per day on this list
  • No third-party test or batch report on the product page
  • No guarantee term stated beside the product

$$$ · one capsule a day Clean label, catalogue price

Proposed change 7 · Dr. Mercola card: who it suits waits on your verdict

Same move: the card ends on who should still buy it.

Last line of the card: “Who it suits: the buyer who already shops with Mercola.”

What the page admitstheirs at 88% of the wordstheirs only
Theirs, in our words
#55at 87%●○○○○fine · 19 words

The small print changes for the last card: results are said to rest on what the product's own label and advertising state.

Why it works. Legal cover, and an accidental admission of method.

Why it sits here, and how it is written

Template position, the foot of the card. It is the last line of the ranking proper, directly above the winner's return.

The one disclaimer that tells the truth about the method: the rival was judged from its label. It contradicts the headline's claim of testing.

Planned for ours, before we wrote: kept the move. This is the honest version of the method, and it is ours: CS-P1 says in its intro that every label was read. Say it once, in the method, not in small print.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What happens, week by weekours at 67%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
The honest week-by-week timeline

Astaxanthin works on a clock, and no product on this list can rush it. The one thing that changes the clock is whether you are still taking it. Here is the map our #1 pick prints on its own page.

• Weeks 1–2: Most people feel steadier energy first, and less of the afternoon slump. • Weeks 2–4: Eye strain relief usually lands here. Small print gets easier. • Weeks 4–8: Bloating eases, and skin starts to firm up. • Weeks 8–12: The window when kidney labs are usually re-drawn.

Any product promising to fix this in a week is selling you the label. The cells take weeks of the full dose, every day. Which is why the routine matters more than the marketing.

The guaranteeours at 73%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word

30 days risk-free, keep the bag 12 mg in one softgel Lab tested , every batch

Reader commentsours at 73%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
What readers who tried our #1 pick are saying

184 Comments Most relevant

Denise R.

My eye drops are still in the drawer. Three weeks in and I read the paper in the morning without them. I scanned the code on the bag first, which I had never been able to do with any supplement.

👍 212

Like · Reply · 3h

Harold P.

My last labs came back the same or slightly better. My doctor asked what changed. One softgel with breakfast. Four stars only because I wish it came in a 90-count.

❤️ 121

Like · Reply · 6h

Margaret L.

I had no idea most of my vitamins were being flushed. The explanation on the page made sense of ten years of buying bottles. The afternoons are different now.

👍 98

Like · Reply · 9h

Tom W.

First one I have finished a whole bag of. One with lunch. My knees are quieter on the stairs, and I like knowing the batch was tested.

👍 64

Like · Reply · 1d

Questions and answersours at 80%ours only
Theirs, in our words

Nothing on their page does this job here.

Ours, word for word
Frequently asked questions
How much do I take?

One softgel a day with a meal that has some fat in it — eggs, yogurt, olive oil, avocado. Astaxanthin is fat-soluble, so food helps your body absorb the full 12 mg.

Will it help my kidney numbers?

It works upstream of the numbers, on the stress inside the cells that do your kidneys’ filtering work. It is fat-soluble, so it settles into cell membranes instead of being processed as kidney waste. It is a supplement, not a treatment. Keep working with your doctor and keep getting your labs done.

When will I notice something?

Weeks 1–2: most people feel steadier energy first. Weeks 2–4: eye strain relief usually lands. Weeks 4–8: bloating eases and skin starts to firm up. Weeks 8–12: the window when kidney labs are usually re-drawn. Take it daily and give it the full 12 weeks.

Is it safe with my medications?

Astaxanthin is a natural carotenoid with a long safety record. It does not interfere with common blood-pressure, diabetes or water-pill medicines. If you take blood thinners, or have a diagnosed kidney condition, check with your doctor first.

What is the guarantee?

30 days, money-back. Take it daily for up to 30 days. If the energy has not lifted and the eyes and joints have not eased, email for a full refund and keep the bag. No restocking fee, no small print.

The closetheirs at 89% of the words · ours at 90%
Theirs, in our words
#56at 88%●●●●○h2 · p · 27 words

A heading re-crowns the seller's product. The tester then enlarges her claim: more than fifty products examined, and a single brand that met every requirement.

Why it works. Re-open the sale for the reader who scrolled through all five cards. earned-authorityexclusivityspecificity

Why it sits here, and how it is written

At the foot of the ranking the reader has just seen the weakest product. The page brings the winner back at once, before attention drops, with a larger number that raises the cost of doubting.

The pool grows tenfold from the headline with no explanation. The sentence ends on a colon to pull the eye into the list. Treat the larger number as invented.

Planned for ours, before we wrote: kept the move. CS-P1 ends on a final CTA block about the product that passed all three tests, after the timeline, comments and FAQ; it has no re-crowning section with a recap list directly under the last rival. Add one. The count stays at five, which is what we read.

See these lines on their page ↗
Ours, word for word
Ready to try the one that passed all three tests?

The Cell Shield puts the full 12 mg in one softgel, is third-party lab tested, and ships free from the maker. That is the whole difference, and it is the one that shows up on your next labs.

Why this onetheirs at 91% of the wordstheirs only
Theirs, in our words
#57at 89%●●●○○3× p · 23 words

The first three ticks of the recap repeat dose, source and delivery, each with a bracketed reason of a few words.

Why it works. Replay the criteria as a checklist the winner completes. loop-closedreason-why

Why it sits here, and how it is written

Third pass through the same three points: criteria, pros, recap. By now the reader can recite them, which is the aim: the yardstick has become their own.

Brackets replace the colons of the pros list, so the recap looks fresh while saying the same thing. One bracket credits the source with better absorption, a point the criteria never argued.

Planned for ours, before we wrote: kept the move. Recap our three bars in their order: the full 12 mg in one softgel (b7, b9), third-party lab tested (c1, c3), cost per day. CS-P1 has a proof bar with three short items but no ticked recap beside the winner's name. b7b9c1c3

See these lines on their page ↗
#58at 90%●●○○○2× p · 15 words

Two more ticks: outside testing the buyer can verify, and a free-from label with no fillers.

Why it works. Carry the trust points into the close. borrowed-authorityreason-why

Why it sits here, and how it is written

They follow the three criteria in the order the pros list used, so the recap reads as that list in miniature.

One bracket promises the buyer can check purity and strength, yet nothing on the page links to a report. The promise is not kept.

Planned for ours, before we wrote: our proof in its place. Ours can keep the promise: third-party lab tested every batch (c3), against about 64% of unverified products failing (c1). CS-P1 states it in the winner card and the proof bar. c1c3

See these lines on their page ↗
Ours, word for word

Nothing on our page today.

Proposed change 10 · New: the short version, after the last rival waits on your verdict

The kept pages restate the standards between the last rival and the close, for the reader who skipped the cards, and end on a rule she can use on any bottle. Ours goes from the fifth card straight to the timeline.

Heading: “The short version of this ranking, for your kidneys, brain, eyes and joints”. Body: “Before you buy any astaxanthin softgel, ask three questions. Is the full 12 mg in one softgel? Is it third-party lab tested? What does a day cost? Our #1 pick, The Cell Shield, is the only product here to score 10 out of 10 on the first two. The Cell Shield costs from $0.60 a day on the 5-bag supply. Our rule of thumb: count the softgels it takes to reach 12 mg, then look for verified third-party lab results.”

The offertheirs at 93% of the wordstheirs only
Theirs, in our words
#59at 91%●●●○○2× p · 17 words

The last two ticks are the ninety-day refund, described as time enough to judge, and the price of $29.99 with the discount ceiling.

Why it works. Put guarantee and price back in front of the reader just before the name. risk-reversalanchoring

Why it sits here, and how it is written

Third statement of the price and fourth of the guarantee. They close the checklist so the final items read before the brand name are the two that lower the cost of saying yes.

Eight and nine words. The label claims best value, although two products in the ranking cost less per softgel.

Planned for ours, before we wrote: our offer in its place. 30-Day Money-Back Guarantee, keep the bag; $29.99 for one bag, $59.97 for three, $89.95 for five, free shipping (BRAND section 3, x4 on the five-bag tier). CS-P1's CTA blocks carry this; a recap list would restate it. x4

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The closetheirs at 94% of the wordstheirs only
Theirs, in our words
#60at 92%●●○○○p · 4 words

A sentence of four words gives the brand's name as the answer to the checklist.

Why it works. Pay off the colon that opened the recap. loop-closed

Why it sits here, and how it is written

It comes after the ticks, not before, so the name arrives as a conclusion. The reader has known it since card one; the delay is for rhythm.

Short, flat, final. The reveal is cadence, not news.

Planned for ours, before we wrote: kept the move. If we add a recap, it ends on the full noun: The Cell Shield, from CellScience. CS-P1's final heading alludes to the winner without naming it.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

Why this onetheirs at 94% of the wordstheirs only
Theirs, in our words
#61at 93%●●●○○h2 · 2× p · 28 words

A heading promises what sets the brand apart. Two matched sentences follow: most brands are the work of marketers after margin; this one comes from a team that minds what gets into the cell.

Why it works. Give the brand a motive, and the category a worse one. common-enemycontrastidentification

Why it sits here, and how it is written

After the facts, a character argument. It is kept for the close because near the top it would sound like advertising; here it follows five cards of apparent fairness.

Two twelve-word sentences built as a mirror: same verb, opposite makers. It is the page's one flash of rhetoric, and it sits oddly beside rival cards that called those rivals honest.

Planned for ours, before we wrote: our own explanation in its place. Their page points at the cell and has no name for what happens there. Ours has: The Cell Shield, astaxanthin spanning the whole cell membrane where vitamin C and E stop short (m2, p3, r5). CS-P1 uses the name in the winner title and the buttons and explains the idea in its intro, but never joins the two in one line. m2p3r5

See these lines on their page ↗
#62at 94%●●●○○p · 30 words

One paragraph says every requirement is met on purpose, admits this costs more to produce, and claims it is the only route to a result the reader can feel.

Why it works. Justify the price with cost of production and promise a felt result. reason-whycandorhope

Why it sits here, and how it is written

The reason for the price comes after the motive and immediately before the link: the reader about to click gets an explanation for why a product this complete is not the cheapest on the list.

Thirty words. The cost admission is a classic reason-why. The felt result is the closest the page comes to promising an outcome, and it names none.

Planned for ours, before we wrote: rewritten to our claims. Where they promise an unnamed feeling, the gate lets us name what the reader notices and when: steadier energy in weeks one to two (r7), eye strain relief in 14 to 28 days (b6), kidney labs re-drawn at weeks eight to twelve (r10). CS-P1 has this as its week-by-week timeline. r7b6r10

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The buttontheirs at 97% of the words · ours at 92%
Theirs, in our words
#63at 95%●●●○○p · 5 words

The second link out repeats the first word for word: a soft invitation to read more about the winner.

Why it works. Catch the reader persuaded by the closing argument. commitmentease

Why it sits here, and how it is written

It follows the argument about what sets the brand apart, about sixty percent of the page after the first link. The long gap is the price of the review pose: no link sits inside or between the rival cards.

Identical wording builds no escalation; the harder ask is held for the last line.

Planned for ours, before we wrote: kept the move. CS-P1 spaces its CTA blocks more evenly (after the winner, mid-page, at the end) and has a sticky bar, so our reader is never sixty percent of a page from a button. Keep ours.

See these lines on their page ↗
Ours, word for word
Try The Cell Shield Risk-Free Free US shipping · 30-day money-back guarantee
One-time purchase · 30-day money-back guarantee · Free US shipping
sidebar card
Editor's Pick #1 pick for kidneys, brain, eyes and joints
CellScience™ Astaxanthin 12mg — The Cell Shield
  • The full 12 mg in one softgel
  • Third-party lab tested, every batch
  • Natural microalgae · no heavy metals
  • 30-day money-back · keep the bag

4.9 · 2,847 verified customers

Check The Cell Shield Availability 🔒 30-day guarantee · Free US shipping

The closetheirs at 98% of the wordstheirs only
Theirs, in our words
#64at 96%●●●○○h2 · 2× p · 27 words

Under a final bottom-line heading, a conditional piece of advice (anyone taking the ingredient should take an effective dose), then the four requirements as four clipped fragments.

Why it works. Reduce the whole page to a rule and a checklist the reader can carry away. reason-whyspecificitycommitment

Why it sits here, and how it is written

The close speaks about the category, not the brand, which returns the page to its opening pose as advice. Coming after the second link, it serves the reader who is still reading and so still undecided.

The four fragments are the best rhythm in the close: a number, a place, a format, a test, each ending on a full stop. The conditional opener is sixteen plain words.

Planned for ours, before we wrote: kept the move. CS-P1's final paragraph names its three points in one sentence. Breaking them into fragments (12 mg in one softgel; third-party lab tested; one softgel a day) would read better aloud for our reader. Rests on b7, b9, c3. b7b9c3

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What is at staketheirs at 99% of the wordstheirs only
Theirs, in our words
#65at 97%●●●○○p · 10 words

A single sentence warns that accepting a lesser product means wasted money.

Why it works. End the argument on loss, the same stake the deck opened with. loss-aversionloop-closed

Why it sits here, and how it is written

It is the last sentence before the final link. The deck promised to separate working products from costly duds; this line closes that loop and leaves the reader with the cost of inaction.

Ten words, second person, no hedging. It is the only stakes line on the page and it is about money, not health.

Planned for ours, before we wrote: rewritten to our claims. Our stake is a true number: about 64% of unverified astaxanthin products fail potency testing (c1), so an untested bottle is a coin toss. CS-P1's final paragraph ends on benefit and has no loss line. c1

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

The buttontheirs at 100% of the wordstheirs only
Theirs, in our words
#66at 98%●●●●○p · 7 words

The final link changes the ask: try the winner, with the ninety-day risk-free window written into the link itself.

Why it works. Make the hard ask, with the guarantee as its wording. risk-reversalcommitment

Why it sits here, and how it is written

Only the last link asks for a trial; the two before asked for a look. The escalation is saved for the reader who has read everything and needs the risk removed, not more information.

Seven words. The verb of trying plus the window makes the guarantee the call to action. It is the strongest of the three links.

Planned for ours, before we wrote: our offer in its place. CS-P1's buttons already follow this pattern with the noun in them (try The Cell Shield, risk-free). The 30-Day Money-Back Guarantee is named in the line under the button.

See these lines on their page ↗
Ours, word for word

Nothing on our page. The plan on the left says why.

What the page admitstheirs at 70% of the words · ours at 96%in a different place on their page
Theirs, in our words
#49at 71%●○○○○fine · 22 words

The same leftover small print a third time, crediting another publisher's ranking system.

Why it works. Legal cover, left unedited.

Why it sits here, and how it is written

Template position, the foot of every rival card.

Identical to the lines under cards two and three.

Planned for ours, before we wrote: left out. Nothing to take; CS-P1 has no per-card small print.

See these lines on their page ↗
Ours, word for word

Ad Disclosure: This article has ads. The Healthy Aging Review may earn a fee when you buy through links on this page. Results may vary. These statements have not been evaluated by the FDA. Products aren’t intended to diagnose, treat, cure, or prevent any disease. CellScience Astaxanthin is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. If you take blood thinners, have a diagnosed kidney condition, are pregnant, nursing or on medication, check with your doctor firs